The efficacy of GABAergic precursor cells transplantation in alleviating neuropathic pain in animal models: a systematic review and meta-analysis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Current therapies are quite unsuccessful in the management of neuropathic pain. Therefore, considering the inhibitory characteristics of GABA mediators, the present systematic review and meta-analysis aimed to determine the efficacy of GABAergic neural precursor cells on neuropathic pain management. Methods: Search was conducted on Medline, Embase, Scopus, and Web of Science databases. A search strategy was designed based on the keywords related to GABAergic cells combined with neuropathic pain. The outcomes were allodynia and hyperalgesia. The results were reported as a pooled standardized mean difference (SMD) with a 95% confidence interval (95% CI). Results: Data of 13 studies were analyzed in the present meta-analysis. The results showed that administration of GABAergic cells improved allodynia (SMD = 1.79; 95% CI: 0.87, 271; P < 0.001) and hyperalgesia (SMD = 1.29; 95% CI: 0.26, 2.32; P = 0.019). Moreover, the analyses demonstrated that the efficacy of GABAergic cells in the management of allodynia and hyperalgesia is only observed in rats. Also, only genetically modified cells are effective in improving both of allodynia, and hyperalgesia. Conclusions: A moderate level of pre-clinical evidence showed that transplantation of genetically-modified GABAergic cells is effective in the management of neuropathic pain. However, it seems that the transplantation efficacy of these cells is only statistically significant in improving pain symptoms in rats. Hence, caution should be exercised regarding the generalizability and the translation of the findings from rats and mice studies to large animal studies and clinical trials.
Abstract
Background: Current therapies are quite unsuccessful in the management of neuropathic pain. Therefore, considering the inhibitory characteristics of GABA mediators, the present systematic review and meta-analysis aimed to determine the efficacy of GABAergic neural precursor cells on neuropathic pain management. Methods: Search was conducted on Medline, Embase, Scopus, and Web of Science databases. A search strategy was designed based on the keywords related to GABAergic cells combined with neuropathic pain. The outcomes were allodynia and hyperalgesia. The results were reported as a pooled standardized mean difference (SMD) with a 95% confidence interval (95% CI). Results: Data of 13 studies were analyzed in the present meta-analysis. The results showed that administration of GABAergic cells improved allodynia (SMD = 1.79; 95% CI: 0.87, 271; P < 0.001) and hyperalgesia (SMD = 1.29; 95% CI: 0.26, 2.32; P = 0.019). Moreover, the analyses demonstrated that the efficacy of GABAergic cells in the management of allodynia and hyperalgesia is only observed in rats. Also, only genetically modified cells are effective in improving both of allodynia, and hyperalgesia. Conclusions: A moderate level of pre-clinical evidence showed that transplantation of genetically-modified GABAergic cells is effective in the management of neuropathic pain. However, it seems that the transplantation efficacy of these cells is only statistically significant in improving pain symptoms in rats. Hence, caution should be exercised regarding the generalizability and the translation of the findings from rats and mice studies to large animal studies and clinical trials.
참고문헌 (35)
- Whalley K, "Pain : transplanted precursors halt neuropathic pain", Nat Rev Neurosci, 13, pp.447~ (2012)
- Tate DG, "Depression and pain among inpatients with spinal cord injury and spinal cord disease : differences in symptoms and neurological function", Disabil Rehabil, 35, pp.1204~1212 (2013)
- Kumru H, "The effects of transcranial direct current stimulation with visual illusion in neuropathic pain due to spinal cord injury : an evoked potentials and quantitative thermal testing study", Eur J Pain, 17, pp.55~66 (2013)
- Sharp K, "A rat chronic pain model of spinal cord contusion injury", Methods Mol Biol, 851, pp.195~203 (2012)
- Finnerup NB, "Pain in patients with spinal cord injury", Pain, 154(Suppl 1), pp.S71~S76 (2013)
- Finnerup NB, "Algorithm for neuropathic pain treatment : an evidence based proposal", Pain, 118, pp.289~305 (2005)
- Backonja MM, "Rational multidrug therapy in the treatment of neuropathic pain", Curr Pain Headache Rep, 10, pp.34~38 (2006)
- Marineo G, "Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management : results of a pilot, randomized, controlled trial", J Pain Symptom Manage, 43, pp.87~95 (2012)
- Wolfe D, "Targeted drug delivery to the peripheral nervous system using gene therapy", Neurosci Lett, 527, pp.85~89 (2012)
- Eaton MJ, "A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury", Brain Res, 835, pp.334~339 (1999)
- Polgár E, "Tactile allodynia can occur in the spared nerve injury model in the rat without selective loss of GABA or GABA(A)receptors from synapses in laminae I-II of the ipsilateral spinal dorsal horn", Neuroscience, 156, pp.193~202 (2008)
- McLeod MC, "Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington’s disease", Cell Transplant, 22, pp.2237~2256 (2013)
- Shetty AK, "Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer’s and Parkinson’s diseases", Brain Res, 1638(Pt A), pp.74~87 (2016)
- Jergova S, "Recombinant neural progenitor transplants in the spinal dorsal horn alleviate chronic central neuropathic pain", Pain, 157, pp.977~989 (2016)
- Jergova S, "Analgesic effect of recombinant GABAergic cells in a model of peripheral neuropathic pain", Cell Transplant, 25, pp.629~643 (2016)
- Hwang I, "Intrathecal transplantation of embryonic stem cell-derived spinal GABAergic neural precursor cells attenuates neuropathic pain in a spinal cord injury rat model", Cell Transplant, 25, pp.593~607 (2016)
- Sistrom CL, "A simple method for obtaining original data from published graphs and plots", AJR Am J Roentgenol, 174, pp.1241~1244 (2000)
- Hooijmans CR, "SYRCLE’s risk of bias tool for animal studies", BMC Med Res Methodol, 14, pp.43~ (2014)
- Wei D, "The use of GRADE approach in systematic reviews of animal studies", J Evid Based Med, 9, pp.98~104 (2016)
- IntHout J, "The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method", BMC Med Res Methodol, 14, pp.25~ (2014)
- Wang D, "Application of Stata software to test heterogeneity in meta-analysis method", Zhonghua Liu Xing Bing Xue Za Zhi, 29, pp.726~729 (2008)
- Bráz JM, "Forebrain GABAergic neuron precursors integrate into adult spinal cord and reduce injuryinduced neuropathic pain", Neuron, 74, pp.663~675 (2012)
- Bráz JM, "Transplant-mediated enhancement of spinal cord GABAergic inhibition reverses paclitaxel-induced mechanical and heat hypersensitivity", Pain, 156, pp.1084~1091 (2015)
- Eaton MJ, "Potential for cell-transplant therapy with human neuronal precursors to treat neuropathic pain in models of PNS and CNS injury: comparison of hNT2.17 and hNT2.19 cell lines", Pain Res Treat, 2012, pp.356412~ (2012)
- Eaton MJ, "Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain", Cell Transplant, 8, pp.87~101 (1999)
- Etlin A, "Functional synaptic integration of forebrain GABAergic precursors into the adult spinal cord", J Neurosci, 36, pp.11634~11645 (2016)
- Jergova S, "Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats : a pharmacologic and neurophysiological evaluation", Exp Neurol, 234, pp.39~49 (2012)
- Juarez-Salinas DL, "GABAergic cell transplants in the anterior cingulate cortex reduce neuropathic pain aversiveness", Brain, 142, pp.2655~2669 (2019)
- Kim DS, "Transplantation of GABAergic neurons from ESCs attenuates tactile hypersensitivity following spinal cord injury", Stem Cells, 28, pp.2099~2108 (2010)
- Mukhida K, "Spinal GABAergic transplants attenuate mechanical allodynia in a rat model of neuropathic pain", Stem Cells, 25, pp.2874~2885 (2007)
- Vaysse L, "GABAergic pathway in a rat model of chronic neuropathic pain : modulation after intrathecal transplantation of a human neuronal cell line", Neurosci Res, 69, pp.111~120 (2011)
- Manion J, "Human induced pluripotent stem cell-derived GABAergic interneuron transplants attenuate neuropathic pain", Pain, 161, pp.379~387 (2020)
- Bao S, "Genetic engineering : pros versus cons in deciphering disease mechanism", Sci Insights, 2016, pp.e00258~ (2016)
- Colloca L, "Neuropathic pain", Nat Rev Dis Primers, 3, pp.17002~ (2017)
- Meacham K, "Neuropathic pain: central vs. peripheral mechanisms", Curr Pain Headache Rep, 21, pp.28~ (2017)
